Clinical Trial Update: Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

View source ↗

Summary

A completed clinical trial update assessing the real-world effectiveness of adalimumab (Humira) for scalp and nail involvement in patients with moderate-to-seve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Moderate to Severe Plaque Psoriasis | Status: COMPLETED | Results posted: 2014-08-07